Symbiotec Pharmalab Surges 16% on 10-Year Protein Deal

Symbiotec Pharmalab Surges 16% on 10-Year Protein Deal

Symbiotec Pharmalab hit a day high of Rs 1,472.70, up about 16%, after the firm signed a 10-year protein deal and posted higher Q2 profit. Symbiotec Pharmalab Limited told exchanges on 6 November that it has signed a 10-year agreement with a European alternative-protein company. It is a take-or-pay deal,...